GlassScriptCardiva Vascade 5f Vcs
Payments companies reported to CMS as associated with Cardiva Vascade 5f Vcs. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cardiva Vascade 5f Vcs, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cardiva Vascade 5f Vcs
These are the largest totals companies reported as associated with Cardiva Vascade 5f Vcs. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Delurgio | Atlanta, GA | Clinical Cardiac Electrophysiology | $18,887.00 |
| Nouri Al Khaled | Evergreen Park, IL | Cardiovascular Disease | $12,000.00 |
| Bryan Cotton | Nashville, TN | Trauma Surgery | $9,861.65 |
| Hugh Mcelderry | Birmingham, AL | Clinical Cardiac Electrophysiology | $8,684.91 |
| Ravi Veeraswamy | Charleston, SC | Vascular Surgery | $6,013.68 |
| Matthew Recht | Cincinnati, OH | Vascular Surgery | $4,000.00 |
| Amin Al-Ahmad | Austin, TX | Clinical Cardiac Electrophysiology | $1,500.00 |
| Zayd Eldadah | Washington, DC | Clinical Cardiac Electrophysiology | $1,500.00 |
| Bhavanadhar Penta | New York, NY | Interventional Cardiology | $913.15 |
| Manish Vinayak | New York, NY | $724.71 |
Prescribed Cardiva Vascade 5f Vcs?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.